Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L Green

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Microbiology|February 23, 2023
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines <i>in vitro</i> and <i>in vivo</i>Kyle Ernzen, Corrine Melvin, Lianbo Yu, et al.
Blood|January 21, 2006
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1Joshua Arnold, Brenda Yamamoto, Min Li, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2018
SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft miceKarthik M Kodigepalli, Minghua Li, Serena Bonifati, et al.
Plos One|March 22, 2019
HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1Jacob Al-Saleem, Wessel P Dirksen, Michael P Martinez, et al.
Frontiers in Immunology|August 12, 2022
HTLV-1 intragenic viral enhancer influences immortalization phenotype <i>in vitro</i>, but is dispensable for persistence and disease development in animal modelsVictoria Maksimova, Susan Smith, Jaideep Seth, et al.
Viruses|October 14, 2011
Molecular determinants of human T-lymphotropic virus type 1 transmission and spreadMichael D Lairmore, Rajaneesh Anupam, Nadine Bowden, et al.
Journal of Virology|January 29, 2016
Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 PathogenesisAmanda R Panfil, Nathan J Dissinger, Cory M Howard, et al.
Retrovirology|February 15, 2013
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individualsYoshimi Enose-Akahata, Anna Abrams, Raya Massoud, et al.
Plos Pathogens|June 16, 2023
HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease developmentVictoria Maksimova, Tasha Wilkie, Susan Smith, et al.
Journal of Virology|March 16, 2006
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivoHajime Hiraragi, Seung-Jae Kim, Andrew J Phipps, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Microbiology|February 23, 2023
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines <i>in vitro</i> and <i>in vivo</i>Kyle Ernzen, Corrine Melvin, Lianbo Yu, et al.
Blood|January 21, 2006
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1Joshua Arnold, Brenda Yamamoto, Min Li, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2018
SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft miceKarthik M Kodigepalli, Minghua Li, Serena Bonifati, et al.
Plos One|March 22, 2019
HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1Jacob Al-Saleem, Wessel P Dirksen, Michael P Martinez, et al.
Frontiers in Immunology|August 12, 2022
HTLV-1 intragenic viral enhancer influences immortalization phenotype <i>in vitro</i>, but is dispensable for persistence and disease development in animal modelsVictoria Maksimova, Susan Smith, Jaideep Seth, et al.
Viruses|October 14, 2011
Molecular determinants of human T-lymphotropic virus type 1 transmission and spreadMichael D Lairmore, Rajaneesh Anupam, Nadine Bowden, et al.
Journal of Virology|January 29, 2016
Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 PathogenesisAmanda R Panfil, Nathan J Dissinger, Cory M Howard, et al.
Retrovirology|February 15, 2013
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individualsYoshimi Enose-Akahata, Anna Abrams, Raya Massoud, et al.
Plos Pathogens|June 16, 2023
HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease developmentVictoria Maksimova, Tasha Wilkie, Susan Smith, et al.
Journal of Virology|March 16, 2006
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivoHajime Hiraragi, Seung-Jae Kim, Andrew J Phipps, et al.
Pageof 8